These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6893792)

  • 21. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
    Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
    J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous regression of lymphosarcoma in a dog.
    Schwartz SN
    J Am Vet Med Assoc; 1988 Jan; 192(2):222-4. PubMed ID: 3350750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma.
    Hahn KA; Richardson RC; Hahn EA; Chrisman CL
    Vet Pathol; 1994 Sep; 31(5):528-40. PubMed ID: 7801430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of a pulmonary component of multicentric lymphosarcoma with bronchoalveolar lavage in two dogs.
    Yohn SE; Hawkins EC; Morrison WB; Reams RY; DeNicola DB; Blevins WE
    J Am Vet Med Assoc; 1994 Jan; 204(1):97-101. PubMed ID: 8125829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonographic features of splenic lymphosarcoma in dogs: 12 cases (1980-1986).
    Wrigley RH; Konde LJ; Park RD; Lebel JL
    J Am Vet Med Assoc; 1988 Dec; 193(12):1565-8. PubMed ID: 3063705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma.
    Kaiser CI; Fidel JL; Roos M; Kaser-Hotz B
    J Am Anim Hosp Assoc; 2007; 43(2):85-92. PubMed ID: 17339285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic significance of histologic grade, pgp, and p53 expression in canine lymphoma.
    Dhaliwal RS; Kitchell BE; Ehrhart E; Valli VE; Dervisis NG
    J Am Anim Hosp Assoc; 2013; 49(3):175-84. PubMed ID: 23535752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastric lymphomas and pseudolymphomas].
    Chabloz R; Givel JC; Saraga P; Saegesser F
    Helv Chir Acta; 1980 Dec; 47(5):547-53. PubMed ID: 7204076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
    Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
    Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
    Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
    Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
    J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenic and hepatic ultrasound and cytology in canine lymphoma: effects of findings on stage migration and assessment of prognosis.
    Nerschbach V; Eberle N; Joetzke AE; Hoeinghaus R; Hungerbuehler S; Mischke R; Nolte I; Betz D
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():82-94. PubMed ID: 25470748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
    Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
    J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological studies on primary reticulosis of the canine brain.
    Vandevelde M; Fatzer R; Fankhauser R
    Vet Pathol; 1981 Sep; 18(5):577-88. PubMed ID: 6895132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Marconato L; Bonfanti U; Stefanello D; Lorenzo MR; Romanelli G; Comazzi S; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmonellosis in dogs with lymphosarcoma.
    Calvert CA; Leifer CE
    J Am Vet Med Assoc; 1982 Jan; 180(1):56-8. PubMed ID: 6895747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.